karen
Team Finds Gene That Promotes Drug Resistance In Cancer
Findings could lead to better diagnoses, new therapies ... Read more
Part Two: Myeloma Doctor Becomes Myeloma Patient
Dr. Bruce Avery has a hematology and oncology practice in Knoxville, Tennessee, and treats multiple myeloma patients. When he himself was diagnosed with multiple myeloma a ... Read more
Part One: Myeloma Doctor Becomes Myeloma Patient
Dr. Bruce Avery has a hematology and oncology practice in Knoxville, Tennessee, and treats multiple myeloma patients. When he himself was diagnosed with multiple myeloma a ... Read more
Pomalidomide To Be Reviewed By FDA Advisory Committee
The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will review Celgene Corporation’s new drug application for pomalidomide at a meeting on November ... Read more
FDA Approves Kyprolis (Carfilzomib) For Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has approved Kyprolis (carfilzomib) for multiple myeloma patients who have failed to respond to at least two ... Read more
Study Shows No Difference Between Bone Drugs For Multiple Myeloma
Many patients with multiple myeloma have symptoms of bone disease and take drugs called bisphosphonates to treat their bone symptoms and bone damage. Bisphosphonates used in ... Read more
Myeloma Patient Writes Book About Living With Cancer
Jane Rubey, a retired food and nutrition professional who lives in Northern California, has written a book called, “Surprise! I’m Still Here!!” about living with ... Read more
Benefits Outweigh Risks with Myeloma Drug Revlimid
Concerns about a possible link between Revlimid® (lenalidomide) and secondary cancers were raised during the American Society of Hematology (ASH) annual meeting in December 2010, ... Read more
New Studies Very Encouraging For Amyloidosis Patients
Two reports published online February 13 in the journal Blood show some of the best responses ever in amyloidosis, a condition that shares characteristics with ... Read more
Risks Outweigh Benefits of Allogeneic Transplant in Multiple Myeloma
A study presented at the American Society of Hematology 52nd Annual Meeting finds the toxicity associated with allogeneic transplantation outweighs possible benefit of reduced relapse ... Read more
Author info
karenLatest comments
karen
on
10/26/2012 00:07:36
